Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2015

Open Access 01-12-2015 | Research

Parity and diabetes risk among hispanic women from Colombia: cross-sectional evidence

Authors: Pablo Cure, Heather J Hoffman, Carlos Cure-Cure

Published in: Diabetology & Metabolic Syndrome | Issue 1/2015

Login to get access

Abstract

Objective

The association between parity and type 2 diabetes has been studied in developed countries and in Singapore and Chinese women but not in Hispanics. Herein we evaluated the association between parity (number of live births) with diabetes in a group of Hispanic postmenopausal women from Colombia.

Research design and methods

Herein we evaluated the association between parity and diabetes in a population of 1,795 women from Colombia. Women were divided in birth categories (0 [referent], 1 or 2, 3–5, 6 or > births). Medical history of diabetes and anthropometric characteristics were recorded. Logistic regressions were performed in order to find the association between parity and diabetes in bivariable and multivariable models after controlling for age, body mass index (BMI), waist hip ratio (WHR) and diabetes family history, among other variables.

Results

In our study, there was an association between parity and diabetes after adjusting for age, BMI and diabetes family history in the multiparous women groups when compared to the women with no births (Referent group) [1–2 births vs. referent OR 5.2 (95 CI 1.2–22.9), 3–5 births vs. referent OR 5.5 (1.3–23.0) and ≥6 births vs. referent OR 7.5 (1.8–31.8), respectively]. The association was maintained in two of the groups in the multivariable analysis [OR 5.0 (1.1–22.9) and 5.3 (1.2–23.5)], for 1 or 2 births and 6 or > births versus 0 births, respectively. Positive diabetes family history and WHR were also associated with an increased risk of diabetes [OR 4.6 (3.0–7.0) and 4.1 (2.0–8.1), respectively].

Conclusions

In postmenopausal Hispanic women, multiparity, as well as a positive family history of diabetes and a high waist-hip ratio were associated with higher diabetes risk.
Literature
1.
go back to reference Desoye G, Schweditsch MO, Pfeiffer KP, Zechner R, Kostner GM. Correlation of hormones with lipid and lipoprotein levels during normal pregnancy and postpartum. J Clin Endocrinol Metab. 1987;64(4):704–12.CrossRefPubMed Desoye G, Schweditsch MO, Pfeiffer KP, Zechner R, Kostner GM. Correlation of hormones with lipid and lipoprotein levels during normal pregnancy and postpartum. J Clin Endocrinol Metab. 1987;64(4):704–12.CrossRefPubMed
2.
go back to reference Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA. 2005;294(21):2751–7.CrossRefPubMed Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA. 2005;294(21):2751–7.CrossRefPubMed
3.
go back to reference Ledoux F, Genest J, Nowaczynski W, Kuchel O, Lebel M. Plasma progesterone and aldosterone in pregnancy. Can Med Assoc J. 1975;112(8):943–7.PubMedCentralPubMed Ledoux F, Genest J, Nowaczynski W, Kuchel O, Lebel M. Plasma progesterone and aldosterone in pregnancy. Can Med Assoc J. 1975;112(8):943–7.PubMedCentralPubMed
4.
go back to reference Kaaja R, Laivuori H, Laakso M, Tikkanen MJ, Ylikorkala O. Evidence of a state of increased insulin resistance in preeclampsia. Metabolism. 1999;48(7):892–6.CrossRefPubMed Kaaja R, Laivuori H, Laakso M, Tikkanen MJ, Ylikorkala O. Evidence of a state of increased insulin resistance in preeclampsia. Metabolism. 1999;48(7):892–6.CrossRefPubMed
5.
6.
go back to reference Ryan EA, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab. 1988;67(2):341–7.CrossRefPubMed Ryan EA, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab. 1988;67(2):341–7.CrossRefPubMed
7.
go back to reference Lao XQ, Thomas GN, Jiang CQ, Zhang WS, Yin P, Schooling M, et al. Parity and the metabolic syndrome in older Chinese women: the Guangzhou Biobank Cohort Study. Clin Endocrinol (Oxf). 2006;65(4):460–9.CrossRef Lao XQ, Thomas GN, Jiang CQ, Zhang WS, Yin P, Schooling M, et al. Parity and the metabolic syndrome in older Chinese women: the Guangzhou Biobank Cohort Study. Clin Endocrinol (Oxf). 2006;65(4):460–9.CrossRef
8.
go back to reference Gunderson EP, Jacobs Jr DR, Chiang V, Lewis CE, Tsai A, Quesenberry Jr CP, et al. Childbearing is associated with higher incidence of the metabolic syndrome among women of reproductive age controlling for measurements before pregnancy: the CARDIA study. Am J Obstet Gynecol. 2009;201(2):177. e171–9.CrossRefPubMedCentralPubMed Gunderson EP, Jacobs Jr DR, Chiang V, Lewis CE, Tsai A, Quesenberry Jr CP, et al. Childbearing is associated with higher incidence of the metabolic syndrome among women of reproductive age controlling for measurements before pregnancy: the CARDIA study. Am J Obstet Gynecol. 2009;201(2):177. e171–9.CrossRefPubMedCentralPubMed
9.
go back to reference Kritz-Silverstein D, Barrett-Connor E, Wingard DL. The effect of parity on the later development of non-insulin-dependent diabetes mellitus or impaired glucose tolerance. N Engl J Med. 1989;321(18):1214–9.CrossRefPubMed Kritz-Silverstein D, Barrett-Connor E, Wingard DL. The effect of parity on the later development of non-insulin-dependent diabetes mellitus or impaired glucose tolerance. N Engl J Med. 1989;321(18):1214–9.CrossRefPubMed
10.
go back to reference Araneta MR, Barrett-Connor E. Grand multiparity is associated with type 2 diabetes in Filipino American women, independent of visceral fat and adiponectin. Diabetes Care. 2010;33:385–9.CrossRefPubMedCentralPubMed Araneta MR, Barrett-Connor E. Grand multiparity is associated with type 2 diabetes in Filipino American women, independent of visceral fat and adiponectin. Diabetes Care. 2010;33:385–9.CrossRefPubMedCentralPubMed
11.
go back to reference Mueller NT, Mueller NJ, Odegaard AO, Gross MD, Koh WP, Yuan JM, et al. Higher parity is associated with an increased risk of type-II diabetes in Chinese women: the Singapore Chinese Health Study. BJOG. 2013;120(12):1483–9.PubMedCentralPubMed Mueller NT, Mueller NJ, Odegaard AO, Gross MD, Koh WP, Yuan JM, et al. Higher parity is associated with an increased risk of type-II diabetes in Chinese women: the Singapore Chinese Health Study. BJOG. 2013;120(12):1483–9.PubMedCentralPubMed
12.
go back to reference Tian Y, Shen L, Wu J, Chen W, Yuan J, Yang H, et al. Parity and the Risk of Diabetes Mellitus among Chinese Women: A Cross-Sectional Evidence from the Tongji-Dongfeng Cohort Study. PLoS One. 2014;8:9(8). Tian Y, Shen L, Wu J, Chen W, Yuan J, Yang H, et al. Parity and the Risk of Diabetes Mellitus among Chinese Women: A Cross-Sectional Evidence from the Tongji-Dongfeng Cohort Study. PLoS One. 2014;8:9(8).
13.
go back to reference Manson JE, Rimm EB, Colditz GA, Stampfer MJ, Willett WC, Arky RA, et al. Parity and incidence of non-insulin-dependent diabetes mellitus. Am J Med. 1992;93(1):13–8.CrossRefPubMed Manson JE, Rimm EB, Colditz GA, Stampfer MJ, Willett WC, Arky RA, et al. Parity and incidence of non-insulin-dependent diabetes mellitus. Am J Med. 1992;93(1):13–8.CrossRefPubMed
14.
go back to reference Ness RB, Harris T, Cobb J, Flegal KM, Kelsey JL, Balanger A, et al. Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med. 1993;328(21):1528–33.CrossRefPubMed Ness RB, Harris T, Cobb J, Flegal KM, Kelsey JL, Balanger A, et al. Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med. 1993;328(21):1528–33.CrossRefPubMed
15.
go back to reference Welborn TA, Dhaliwal SS, Bennett SA. Waist-hip ratio is the dominant risk factor predicting cardiovascular death in Australia. Med J Aust. 2003;179(11–12):580–5.PubMed Welborn TA, Dhaliwal SS, Bennett SA. Waist-hip ratio is the dominant risk factor predicting cardiovascular death in Australia. Med J Aust. 2003;179(11–12):580–5.PubMed
16.
go back to reference Molarius A, Seidell JC. Selection of anthropometric indicators for classification of abdominal fatness–a critical review. Int J Obes Relat Metab Disord. 1998;22(8):719–27.CrossRefPubMed Molarius A, Seidell JC. Selection of anthropometric indicators for classification of abdominal fatness–a critical review. Int J Obes Relat Metab Disord. 1998;22(8):719–27.CrossRefPubMed
17.
go back to reference CDC. Prevalence of diabetes among Hispanics: selected areas, 1998–2002. MMWR Morb Mortal Wkly Rep. 2004;53:941–4. CDC. Prevalence of diabetes among Hispanics: selected areas, 1998–2002. MMWR Morb Mortal Wkly Rep. 2004;53:941–4.
18.
go back to reference Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999–2002. Diabetes Care. 2006;29(6):1263–8.CrossRefPubMed Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999–2002. Diabetes Care. 2006;29(6):1263–8.CrossRefPubMed
19.
go back to reference Lopez-Jaramillo P. Defining the research priorities to fight the burden of cardiovascular diseases in Latin America. J Hypertens. 2008;26(9):1886–9.CrossRefPubMed Lopez-Jaramillo P. Defining the research priorities to fight the burden of cardiovascular diseases in Latin America. J Hypertens. 2008;26(9):1886–9.CrossRefPubMed
20.
go back to reference Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295(13):1549–55.CrossRefPubMed Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295(13):1549–55.CrossRefPubMed
21.
go back to reference Cure-Cure C, Cure P. Validation of cross-sectional studies with long-term longitudinal studies. Osteoporos Int. 2012;23(1):399.CrossRefPubMed Cure-Cure C, Cure P. Validation of cross-sectional studies with long-term longitudinal studies. Osteoporos Int. 2012;23(1):399.CrossRefPubMed
Metadata
Title
Parity and diabetes risk among hispanic women from Colombia: cross-sectional evidence
Authors
Pablo Cure
Heather J Hoffman
Carlos Cure-Cure
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2015
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-015-0001-z

Other articles of this Issue 1/2015

Diabetology & Metabolic Syndrome 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.